PSY FPX 6010 Assessment 1 Noninvasive Prenatal Testing Overview
Phillip April 20, 2024 No Comments

PSY FPX 6010 Assessment 1 Noninvasive Prenatal Testing Overview

PSY FPX 6010 Assessment 1 Noninvasive Prenatal Testing Overview


Capella university

PSY FPX 6010 Human Prenatal Development

Prof. Name


General Information

The health of a fetus is paramount during pregnancy, necessitating the assessment of genetic and chromosomal factors. Various tests, both invasive and noninvasive, are available to detect such risks prenatally (Gross, 2019). Noninvasive prenatal testing (NIPT) has gained popularity since 2011 for its ability to assess genetic abnormalities without posing risks to the fetus (Montgomery & Thayer, 2020). Although NIPT does not diagnose abnormalities, it identifies heightened risks (Montgomery & Thayer, 2020).

Description of NIPT

NIPT analyzes cell-free DNA in a pregnant woman’s blood, carrying minimal risk akin to a routine blood draw (Montgomery & Thayer, 2020). It detects common abnormalities like trisomy 21, 18, and 13 with high accuracy (Samura, 2020). NIPT can also determine fetal sex and is typically performed around the tenth week of gestation (Montgomery & Thayer, 2020).

Benefits and Limitations

NIPT offers psychological benefits, reducing stress for expectant parents (Kater-Kuipers et al., 2018). However, false reassurance is possible due to its imperfect accuracy, and false positives or negatives may occur (Samura, 2019). Despite this, NIPT allows parents time to prepare for potential medical needs of the child and facilitates closer monitoring during pregnancy (Montgomery & Thayer, 2020).

The Genetic Counselor

Genetic counseling plays a crucial role in informing expectant parents about the implications of NIPT results (Kater-Kuipers et al., 2021). Counselors help navigate complex decisions and provide support, including referrals to advocacy groups (Kater-Kuipers et al., 2021).


NIPT serves as a safe and reliable tool for assessing fetal health, particularly in high-risk pregnancies. However, its usage necessitates informed decision-making, potentially aided by genetic counseling.


Azri, S., Larmar, S., & Cartmel, J. (2014). Social work’s role in prenatal diagnosis and genetic services: Current practice and future potential. Australian Social Work, 67(3), 348–362.

Benoy, M.E., Iruretagoyena, J.I., Birkeland, L.E., & Petty, E.M. (2021). The impact of insurance on equitable access to non-invasive prenatal screening (NIPT): private insurance may not pay. Journal of Community Genetics, 12(1), 185-197. doi:10.1007/s12687-020-00498-w

Gross, D. (2019). Infancy: Development from birth to age 3 (3rd ed.). Rowman & Littlefield.

Kater-Kuipers A., Bakkeren, I. M., Riedijk, S. R., Go Attie, T. J. I., Polak, M. G., Galjaard, R. H., . . . Bunnik, E. M. (2021). Non-invasive prenatal testing (NIPT): Societal pressure or freedom of choice? A vignette study of dutch citizens’ attitudes. European Journal of Human Genetics : EJHG, 29(1), 2-10. Doi:

PSY FPX 6010 Assessment 1 Noninvasive Prenatal Testing Overview

Kater-Kuipers, A., Bunnik, E. M., de Beaufort, I. D., & Galjaard, R. (2018). Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. BMC Pregnancy and Childbirth, 18(1), 409.

Labonté, V., Alsaid, D., Lang, B., & Meerpohl, J. J. (2019). Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. BMC Pregnancy and Childbirth, 19(1), 385. doi:

Montgomery, S., & Thayer, Z. M. (2020). The influence of experiential knowledge and societal perceptions on decision-making regarding non-invasive prenatal testing (NIPT). BMC Pregnancy and Childbirth, 20, 1-14. Doi:

PSY FPX 6010 Assessment 1 Noninvasive Prenatal Testing Overview

Samura, O. (2020). Update on noninvasive prenatal testing: A review based on current worldwide research. The Journal of Obstetrics and Gynaecology Research, 46(8), 1246–1254. Doi: